Cognitive behavioural group treatment for social anxiety in schizophrenia

Kingsep, Patrick; Nathan, Paula R.; Castle, David

doi:10.1016/s0920-9964(02)00376-6

Cited by 106 publications

(102 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Targeted anxiety interventions, including cognitive behav ioural therapy, benzodiazepines and selective serotonin reuptake inhibitors, have been shown to positively impact quality of life and symptom severity among individuals with schizophrenia. [48][49][50][51] As negative symptoms are historically dif ficult to treat in schizophrenia, identification and treatment of underlying anxiety has the potential to drastically improve functional outcomes in these individuals. These findings sug gest that social dysfunction may improve with interventions for anxiety in some individuals with schizophrenia, even in the presence of anhedonia.…”

Section: Resultsmentioning

confidence: 99%

Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia

Cieslak

Walsh‐Messinger

Stanford

et al. 2015

J Psychiatry Neurosci

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia

Cieslak

Walsh‐Messinger

Stanford

et al. 2015

J Psychiatry Neurosci

View full text Add to dashboard Cite

“…Few empiric data are available on the treatment of SAD in schizophrenia, with some evidence for the effectiveness of cognitive-behavioral group therapy compared with wait-list control subjects [60,61]. Not only did symptoms of SAD improve in two samples (n=20 and n=33), but mood and quality of life also improved, with treatment gains maintained at a 2-month follow-up.…”

Section: Social Anxiety Disorder and Schizophreniamentioning

confidence: 99%

Anxiety disorders and schizophrenia

Muller

Koen²,

Seedat³

et al. 2004

Curr Psychiatry Rep

View full text Add to dashboard Cite

Anxiety symptoms and disorders have long been described in schizophrenia. This article reviews the epidemiology, phenomenology, and neurobiologic underpinnings of comorbid anxiety symptoms and disorders in schizophrenia. Recent literature was obtained by Medline searches using key words relating to schizophrenia and anxiety symptoms or disorders. There is some evidence that anxiety may be a core symptom dimension in schizophrenia, although further work is required. There is evidence that comorbid obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, and social anxiety disorder are all more common than expected by chance in schizophrenia, although additional work is needed to determine the mechanisms that underlie these associations and their clinical implications. In the interim, however, the data emphasize the importance of assessing and treating comorbid anxiety symptoms and disorders in schizophrenia.

show abstract

“…Fortunately, social anxiety symptoms in patients with psychotic illness are amenable to psychological interventions. Group-based cognitive behaviour therapy, comprising exposure and cognitive techniques and 'homework' assignments was found beneficial in 20 patients undergoing weekly 2-hour sessions over 8 weeks [65], and in 33 patients after 12 sessions [66]. The effects of pharmacological treatments are less certain; switching to aripiprazole was found beneficial in a small (n = 16) sample of patients, with some evidence of persistent benefit at 1-year follow-up [67]; clozapine treatment may worsen social anxiety symptoms, though these can be reduced through treatment with fluoxetine [68].…”

Section: Treatment Of Social Anxiety Symptoms In Psychosismentioning

confidence: 93%

Pharmacological Treatment of Social Anxiety Disorder

Masdrakis

Turic²,

Baldwin³

2013

Modern Trends in Psychiatry

View full text Add to dashboard Cite

Social anxiety disorder (social phobia) is a common and typically long-standing medical condition, characterized by an excessive fear of being observed or evaluated negatively in social or performance situations. Efficacious interventions in acute treatment include cognitive behavioural therapy and a range of medications including many antidepressants, some benzodiazepines and anticonvulsants, and the antipsychotic olanzapine. Most studies report no significant differences in overall efficacy or tolerability between active compounds. Responders to previous acute treatment benefit from continuing active medication for 6 months. Evidence of a dose-response relationship with antidepressant drugs is inconsistent, though only higher doses of pregabalin are efficacious. Switching between treatments with proven efficacy may be helpful. Augmentation of a selective serotonin reuptake inhibitor with buspirone or clonazepam can be beneficial. It is unlikely that combining pharmacotherapy with psychotherapy results in greater overall efficacy compared to either treatment given alone. Proof-of-concept and other preliminary studies suggest the efficacy of psychotherapy can be enhanced through prior administration of D-cycloserine, cannabidiol, or oxytocin.

show abstract

Cognitive behavioural group treatment for social anxiety in schizophrenia

Cited by 106 publications

References 24 publications

Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia

Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophrenia

Anxiety disorders and schizophrenia

Pharmacological Treatment of Social Anxiety Disorder

Contact Info

Product

Resources

About